Open Clinical Trials
ESTEEM - A Multicenter, Global, Observational Study to Collect Information on Safety and to Document the Drug Utilization of Tecfidera™ (Dimethyl Fumarate) When Used in Routine Medical Practice in the Treatment of Multiple Sclerosis.
CLICK - Cladribine tablets: Observational evaluation of effectiveness and patient-reported outcomes (PROs) in suboptiMAlly controlled patientS previously Taking injectable disEase-modifying dRugs (DMDs) for relapsing forms of multiple sclerosis (RMS)
MASTER-2 - A Study of Suboptimally Controlled Participants Previously Taking Oral Disease-Modifying Drugs (DMDs) for Relapsing Forms of Multiple Sclerosis (RMS)
EXCHANGE - Safety and Tolerability of Conversion From Oral, Injectable, or Infusion Disease Modifying Therapies to Dose-titrated Oral Siponimod (Mayzent) in Advancing RMS Patients.
ENLIGHTEN - Study Describing Cognitive Processing Speed Changes in Relapsing Multiple Sclerosis Subjects Treated With Ozanimod (RPC-1063)
CHIMES- Study to Assess Disease Activity and Biomarkers in Minority Participants With Relapsing Multiple Sclerosis (RMS) Before and During Treatment With Ocrelizumab
EXPERIENCE-US - Study of Diroximel Fumarate in the Real-World Setting
ARCADIA - AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenic Stroke (ARCADIA)
SLEEP SMART - Sleep for Stroke Management and Recovery Trial (Sleep SMART)
SATURN - Statins In Intracerbral Hemorrhage (SATURN)
ASPIRE - Anticoagulation in ICH Survivors for Stroke Prevention and Recovery (ASPIRE)
OPTOMIST= Safety Study of Post Intravenous tPA Monitoring in Ischemic Stroke
(TRAILBLAZER-EXT): A Follow-On Study of Donanemab (LY3002813) With Video Assessments in Participants With Alzheimer's Disease (TRAILBLAZER-EXT)